BusinessMyoKardia Begins Patient Dosing in Phase 1b Clinical Study of MYK-491 in Dilated Cardiomyopathy PatientsBy Nasdaq OMXFeb 14, 2018, 1:30 PM UTC
BusinessMyoKardia Announces Pricing of Proposed Public Offering of Common StockBy Nasdaq OMXSep 27, 2016, 10:48 PM UTC
